Myriad Genetics Announces Participation in Healthcare Events

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Regeneron Stock Price Target Adjustment Wells Fargo has recently updated its financial outlook for Regeneron Pharmaceuticals (NASDAQ: REGN), substantially lowering the price target from $1,200 to $1,050. While this indicates a more cautious approach regarding the stock's potential growth, the firm has retained its Overweight rating. This adjustment results from evolving...

Overview of EfTEN Real Estate Fund AS Performance In September, EfTEN Real Estate Fund AS maintained its consolidated rental income at €2,701 thousand, showing stability compared to August. The Fund's consolidated net operating income (NOI) recorded a slight decline to €2,606 thousand, which represents a decrease of €16 thousand from the prior month. This small drop...

Leadership Changes at CONMED Corporation CONMED Corporation (NYSE: CNMD), a leader in medical technology, has announced an important transition in its executive leadership. Curt R. Hartman, the current President and CEO, will retire on January 1, 2025. Taking the reins will be Patrick Beyer, who presently serves as the Chief Operating Officer (COO). Alongside his new role...

Key Stock Sales by OneSpaWorld's CFO Recently, significant stock transactions involving Stephen Lazarus, the Chief Financial Officer and Chief Operating Officer of OneSpaWorld Holdings Ltd (NASDAQ: OSW), took place. Lazarus sold a notable amount of company stock totaling over $486,000 through several transactions. These sales occurred over specific dates, indicating a...

Holafly Celebrates Major Milestone in eSIM Sales In an exciting update, Holafly has successfully sold over 10 million eSIMs globally, marking a significant achievement for the company and laying the foundation for its future endeavors in the travel tech industry. Founded in 2018 by Pedro Maiquez and YingYan Hu, Holafly aims to tackle the challenges faced by international...